Table 4 Serum tumor marker levels of the two groups (\( \overline{\mathrm{X}} \) ±s)
| Project | Test group (n = 208) | Control group (n = 204) | P Value |
|---|---|---|---|
| Before treatment | |||
| CEA (ng/ml) | 96.27 ± 9.57 | 95.38 ± 9.21 | 0.34 |
| NSE (ng/ml) | 88.62 ± 7.52 | 88.01 ± 7.44 | 0.41 |
| CYFRA21-1 (ng/ml) | 37.84 ± 5.90 | 37.58 ± 6.00 | 0.66 |
| CA199 U/ml | 51.83 ± 7.53 | 50.69 ± 7.42 | 0.12 |
| After treatment | |||
| CEA (ng/ml) | 22.68 ± 3.53 | 56.53 ± 7.51 | < 0.0001 |
| NSE (ng/ml) | 25.59 ± 4.53 | 58.19 ± 8.63 | < 0.0001 |
| CYFRA21-1 (ng/ml) | 9.88 ± 0.55 | 22.08 ± 2.37 | < 0.0001 |
| CA199 U/ml | 27.15 ± 4.69 | 47.95 ± 4.56 | < 0.0001 |
